WASHINGTON--(BUSINESS WIRE)--DKT International, one of the largest private providers of family planning products and services in the developing world, is proud to announce the development of DKT WomanCare, a global reproductive health marketing and distribution program. DKT WomanCare provides products to all DKT country-based programs as well as multi-lateral, governmental, commercial, and NGO partners.
As the exclusive global distributor of products like the Ipas MVA and Levoplant contraceptive implant, the new DKT WomanCare website will provide useful product information and ready-to-use marketing and educational materials to help clinicians, program managers, government representatives, and others directly contact in-country distributors to purchase products quickly and effectively in their own currency. The website features an e-commerce “portal” where qualified distributors can purchase directly from DKT WomanCare – an innovation that will reduce the regulatory and commercial complexity of marketing sexual and reproductive health products and medical devices.
“The DKT WomanCare platform will allow us to increase availability and access to reproductive health supplies for more public and private health providers around the globe,” says Chris Purdy, CEO of DKT International. “For example, DKT WomanCare is the exclusive global distributor and marketer of the Ipas MVA technology, currently available in more than 100 countries. It’s the world’s most utilized, safe and effective surgical abortion technology which can also be used to manage early pregnancy loss and endometrial biopsy. DKT WomanCare is also the exclusive global distributor and marketer of Levoplant, a 3-year, WHO-Prequalified contraceptive implant manufactured by Shanghai Dahua Pharmaceutical. It is a long-acting, reversible contraceptive implant (LARC) that provides protection against unwanted pregnancy at a low cost. We acquired WomanCare Global to help us build the sort of sustainable supply chain we needed as we expand the number of countries where we sell products, increase the capacity of trained health providers to deliver services, and support a robust service provision environment.”
DKT WomanCare showcased its products and introduced attendees to its new interactive website, designed to improve knowledge and access of critical reproductive health products at the Innovations Expo as part of the Reproductive Health Supplies Coalition 19th General Membership meeting.
Tracey Brett, DKT WomanCare’s Regulatory Affairs Director, was part of a panel entitled, “What program managers need to know about product registration.” Brett shared experiences and lessons learned ushering the Levoplant implant through the approval and registration process with the World Health Organization’s Collaborative Regulatory Procedure (WHO CRP) to get fast track national regulatory approvals – including successes, challenges, and timelines from submission to approvals.
“We are delighted to launch DKT WomanCare’s new website and have participated in the Innovations Expo in Kathmandu,” adds True Overholt, Marketing Director of DKT WomanCare. “Hundreds of the world’s leaders and experts in reproductive health supplies addressed the hard questions, thought strategically, made connections, and planned for upcoming years. As an integral player in the supply chain that feeds the world’s family planning initiatives, it’s important for DKT WomanCare both to contribute our knowledge and experience and learn from others. We all have the same goal: empowering men and women to determine if and when they will have children – no matter their economic status or circumstance in their countries.”
Since 1989, DKT International’s core mission has been to provide safe and affordable options for family planning and HIV prevention through social marketing in underserved countries throughout Latin America, Africa, and Asia.
